According to a study that assessed plasma brain-derived neurotrophic factor (BDNF) levels before and after BLT in treatment-resistant depression, responders and remitters had higher post-treatment plasma BDNF concentrations than patients who did not achieve response or remission [54]. The gene discussed is BDNF; the disease is depressive symptom measurement.